[EN] DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS<br/>[FR] DÉRIVÉS DE DIFLUOROCYCLOHEXYLE UTILISÉS EN TANT QUE MODULATEURS D'IL -17
申请人:UCB BIOPHARMA SRL
公开号:WO2021204801A1
公开(公告)日:2021-10-14
A series of substituted 4,4-difluorocyclohexyl derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.
本文定义的一系列取代的4,4-二氟环己基衍生物,作为人类IL-17活性的强效调节剂,因此在治疗和/或预防各种人类疾病,包括炎症性和自身免疫性疾病方面具有益处。